Skip to main content
. 2015 Mar 19;148(3):752–758. doi: 10.1378/chest.14-3119

TABLE 3 ] .

Regression Model Results of Time to IPC Removal

Univariate Regression
Variable No. Patients (N = 91) % Subhazard Ratio P Value
Age category
 < 60 y 33 36.26 Reference
 60-70 y 27 29.67 0.79 .63
 > 70 y 31 34.07 0.37 .09
Sex
 Male 65 71.43 Reference
 Female 26 28.57 1.21 .67
Underlying malignancy
 Other 35 38.46 Reference
 Lymphoma 56 61.54 1.06 .89
Chemotherapy activity
 Active 39 42.86 Reference
 Within the past 6 wk 17 18.68 1.28 .65
 > 6 wk ago 23 25.27 0.48 .27
 Unknown 12 13.19 0.99 .98
Pleural space physiology at IPC placement
 Nonexpandable lung 15 16.48 Reference
 Reexpandable lung 18 19.78 2.19 .35
 Not assessed 58 63.74 1.89 .39
Pleural effusion etiology
 MPE (cytology or histology positive) 50 54.95 Reference
 MPE suspected 24 26.37 0.99 .99
 Recurrent exudative effusion 11 12.09 0.81 .79
 Recurrent transudative effusion 6 6.59 0.64 .67

MPE = malignant pleural effusion. See Table 2 legend for expansion of other abbreviation.